Matches in Wikidata for { <http://www.wikidata.org/entity/Q69060790> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q69060790 description "artigo científico (publicado na 1989)" @default.
- Q69060790 description "artikull shkencor i botuar më 01 janar 1989" @default.
- Q69060790 description "artículu científicu espublizáu en 1989" @default.
- Q69060790 description "im Januar 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69060790 description "scientific article published on 01 January 1989" @default.
- Q69060790 description "wetenschappelijk artikel" @default.
- Q69060790 description "наукова стаття, опублікована в січні 1989" @default.
- Q69060790 name "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 name "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 name "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 type Item @default.
- Q69060790 label "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 label "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 label "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 prefLabel "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 prefLabel "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 prefLabel "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 P1433 Q69060790-DDA47A77-02E4-4D8B-A8AB-94FC7928DADC @default.
- Q69060790 P1476 Q69060790-2C2EB095-F771-4B9B-B499-5CB384958E59 @default.
- Q69060790 P2093 Q69060790-1CCC55A1-385B-4911-88E3-F2DDD2B4BEF9 @default.
- Q69060790 P2093 Q69060790-23A2A605-3E8D-446C-9333-670057372551 @default.
- Q69060790 P2093 Q69060790-87032C26-1DD5-4C84-AF79-DC5527AB9395 @default.
- Q69060790 P2093 Q69060790-8EBB6F37-4CF3-4354-B659-90396B5663BB @default.
- Q69060790 P2093 Q69060790-98326EBE-EFE5-4B6D-AD5D-9A46FFAC751B @default.
- Q69060790 P2093 Q69060790-ED41CBFC-AD3A-4E44-8CE0-CA4879C1341B @default.
- Q69060790 P2093 Q69060790-EDB2DE16-D737-49F5-BB25-0BFF12A312CC @default.
- Q69060790 P2093 Q69060790-F9F81B55-5CA0-4D86-94F4-DA9E51215627 @default.
- Q69060790 P2860 Q69060790-BC3504B4-D5BE-44C4-A72E-80476D130D0D @default.
- Q69060790 P2888 Q69060790-8426D279-0BBB-46CC-959C-D0B019FEE208 @default.
- Q69060790 P304 Q69060790-9FEE784C-348A-44D6-8597-9F61A666BF10 @default.
- Q69060790 P31 Q69060790-15E30876-3DBD-4666-8E25-38A43CB05749 @default.
- Q69060790 P356 Q69060790-7F1C71BD-CFAB-41C1-8F21-68E777923C01 @default.
- Q69060790 P433 Q69060790-E6957565-090E-46B2-93D8-1D138C07D94E @default.
- Q69060790 P478 Q69060790-573EF483-CE88-4FDD-8E39-55586A61ED23 @default.
- Q69060790 P577 Q69060790-280A77B9-DA7D-4DC9-B307-F3BC3392DEE7 @default.
- Q69060790 P6179 Q69060790-FEE75EC1-217D-4424-B754-EDC5387B134A @default.
- Q69060790 P698 Q69060790-DFB514F5-8D56-4A93-AAEB-59851A314BA2 @default.
- Q69060790 P921 Q69060790-51B5AD3F-507D-4C1A-A58D-493D2FB6DEC5 @default.
- Q69060790 P921 Q69060790-6D332515-6DDD-4C46-BE62-0DFC2EDD1B55 @default.
- Q69060790 P921 Q69060790-BFEE3B6C-9961-433E-8E7D-93A8012F1CB0 @default.
- Q69060790 P356 BF00292415 @default.
- Q69060790 P698 2468426 @default.
- Q69060790 P1433 Q326137 @default.
- Q69060790 P1476 "300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study" @default.
- Q69060790 P2093 "D Belpomme" @default.
- Q69060790 P2093 "F Heritier" @default.
- Q69060790 P2093 "G Pinon" @default.
- Q69060790 P2093 "M C Delestrain" @default.
- Q69060790 P2093 "M C Pinel" @default.
- Q69060790 P2093 "M Chazard" @default.
- Q69060790 P2093 "P Martin" @default.
- Q69060790 P2093 "R Bugat" @default.
- Q69060790 P2860 Q70368296 @default.
- Q69060790 P2888 bf00292415 @default.
- Q69060790 P304 "331-332" @default.
- Q69060790 P31 Q13442814 @default.
- Q69060790 P356 "10.1007/BF00292415" @default.
- Q69060790 P433 "5" @default.
- Q69060790 P478 "23" @default.
- Q69060790 P577 "1989-01-01T00:00:00Z" @default.
- Q69060790 P6179 "1005103202" @default.
- Q69060790 P698 "2468426" @default.
- Q69060790 P921 Q18556145 @default.
- Q69060790 P921 Q18936 @default.
- Q69060790 P921 Q415588 @default.